John Koreth, MBBS, DPhil

    John Koreth, MBBS, DPhil

    Associate Professor of Medicine, Harvard Medical School
    Senior Physician, Dana-Farber Cancer Institute
    • Should Patients With Myelodysplastic Syndromes Undergo Transplant? Monday, May 1st, 2017

      For patients with myelodysplastic syndromes (MDS), hematopoietic cell transplantation (HCT) is the only potentially curative option, but the rates of transplant-related morbidity and mortality preclude some patients from receiving this intervention. In this edition of Drawing First Blood, ASH Clinical News invited John Koreth, MBBS, DPhil, and Bart Scott, MD, to debate the question “Should [...]

    SHARE